SHANI ALLRED

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SALT LAKE CITY, UT NPI 1700104445

General Payments — all program years on this page

$1,232.55

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $372.25 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $372.2519

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma US Inc $90.164
ABBVIE INC. $77.994
SHIELD THERAPEUTICS INC $75.284
Exeltis, USA Inc. $43.042
Biogen, Inc. $31.032
Novo Nordisk AS $19.491
Hologic Sales and Service, LLC $18.201
Organon LLC $17.061

By program year

Program yearAmountRecords
2021 $175.6310
2022 $401.4822
2023 $283.1918
2024 $372.2519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084881012 Hologic Sales and Service, LLC $18.20 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100492921 Novo Nordisk Inc $19.49 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104836271 Biogen, Inc. $14.70 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104866408 Biogen, Inc. $16.33 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106430354 ABBVIE INC. $18.69 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106430356 ABBVIE INC. $16.33 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106430358 ABBVIE INC. $20.50 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106430360 ABBVIE INC. $22.47 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136192961 Organon Llc $17.06 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139467018 Astellas Pharma US Inc $22.82 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139520117 Astellas Pharma US Inc $21.23 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139533158 Astellas Pharma US Inc $21.37 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139552787 Astellas Pharma US Inc $24.74 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150008370 Exeltis, USA Inc. $13.63 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150008372 Exeltis, USA Inc. $29.41 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150125197 SHIELD THERAPEUTICS INC $16.12 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150135881 SHIELD THERAPEUTICS INC $18.62 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150145548 SHIELD THERAPEUTICS INC $19.85 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150154676 SHIELD THERAPEUTICS INC $20.69 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.